Phase 1 first in man clinical trial to test the safety, pharmacokinetic and pharmacodynamic profile of its lead drug CM101 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2017
At a glance
- Drugs CM 101 (Primary)
- Indications Non-alcoholic steatohepatitis; Pulmonary fibrosis; Sclerosis
- Focus Adverse reactions; First in man
- 08 Dec 2017 New trial record